|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
81,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 7.22 per share. |
11 Jun 2026 |
22,000 |
58,322
(0%)
|
0%
|
7.2 |
158,796
|
Common Stock |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
80,322
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
70,550
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 7.20 per share. |
11 Jun 2026 |
10,800 |
59,750
(0%)
|
0%
|
7.2 |
77,748
|
Common Stock |
|
Adrian M. Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 7.20 per share. |
11 Jun 2026 |
27,000 |
27,000
(0%)
|
0%
|
7.2 |
194,311
|
Common Stock |
|
Adrian M. Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
54,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
102,390
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Sale of securities on an exchange or to another person at price $ 7.20 per share. |
11 Jun 2026 |
11,610 |
90,780
(0%)
|
0%
|
7.2 |
83,579
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Sale of securities on an exchange or to another person at price $ 7.20 per share. |
11 Jun 2026 |
8,100 |
113,858
(0%)
|
0%
|
7.2 |
58,311
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
121,958
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alessandra Cesano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2026 |
27,000 |
68,850
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
227,474 |
227,474
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
159,778 |
7,305,729
(18%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
49,394 |
205,301
(0%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
70,321 |
70,321
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
46,739 |
240,023
(0%)
|
0%
|
|
0
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2026 |
66,541 |
66,541
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.84 per share. |
06 Jan 2026 |
16,938 |
7,163,963
(18%)
|
0%
|
5.8 |
98,986
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.88 per share. |
06 Jan 2026 |
18,012 |
7,145,951
(18%)
|
0%
|
5.9 |
105,893
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 5.84 per share. |
06 Jan 2026 |
3,973 |
160,921
(0%)
|
0%
|
5.8 |
23,218
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 5.88 per share. |
06 Jan 2026 |
5,014 |
155,907
(0%)
|
0%
|
5.9 |
29,477
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.84 per share. |
06 Jan 2026 |
4,540 |
199,689
(0%)
|
0%
|
5.8 |
26,532
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.88 per share. |
06 Jan 2026 |
6,405 |
193,284
(0%)
|
0%
|
5.9 |
37,655
|
Common Stock |
|
Michael P Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 4.86 per share. |
11 Nov 2025 |
20,000 |
54,000
(0%)
|
0%
|
4.9 |
97,228
|
Common Stock |
|
Alessandra Cesano
|
Director |
Sale of securities on an exchange or to another person at price $ 3.37 per share. |
18 Jul 2025 |
27,000 |
41,850
(0%)
|
0%
|
3.4 |
90,909
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
21,580 |
7,180,901
(18%)
|
0%
|
3.5 |
76,285
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
25,592 |
7,202,481
(18%)
|
0%
|
3.5 |
90,417
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
3,443 |
164,894
(0%)
|
0%
|
3.5 |
12,171
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
4,374 |
168,337
(0%)
|
0%
|
3.5 |
15,453
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
3,935 |
204,229
(0%)
|
0%
|
3.5 |
13,910
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
08 Jul 2025 |
5,587 |
208,164
(0%)
|
0%
|
3.5 |
19,739
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
13 Jun 2025 |
22,000 |
53,322
(0%)
|
0%
|
3.4 |
74,800
|
Common Stock |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
13 Jun 2025 |
10,800 |
43,550
(0%)
|
0%
|
3.4 |
36,720
|
Common Stock |
|
Adrian M. Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
13 Jun 2025 |
27,000 |
27,000
(0%)
|
0%
|
3.4 |
91,800
|
Common Stock |
|
Allison Dorval
|
Director |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
13 Jun 2025 |
11,610 |
75,390
(0%)
|
0%
|
3.4 |
39,474
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Sale of securities on an exchange or to another person at price $ 3.39 per share. |
13 Jun 2025 |
8,100 |
94,958
(0%)
|
0%
|
3.4 |
27,459
|
Common Stock |
|
Alessandra Cesano
|
Director |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
13 Jun 2025 |
12,150 |
68,850
(0%)
|
0%
|
3.4 |
41,310
|
Common Stock |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
74,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
75,322
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
54,350
(0%)
|
0%
|
|
0
|
Common Stock |
|
Adrian M. Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
54,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
87,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
103,058
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alessandra Cesano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
27,000 |
81,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
198,399 |
7,228,073
(18%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
274,622 |
274,622
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
48,117 |
172,711
(0%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
66,604 |
66,604
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
85,067 |
85,067
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
61,456 |
213,751
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
66,221 |
66,221
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Feb 2025 |
47,841 |
156,792
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.15 per share. |
02 Jan 2025 |
33,841 |
7,029,674
(17%)
|
0%
|
3.2 |
106,657
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.15 per share. |
02 Jan 2025 |
8,633 |
124,594
(0%)
|
0%
|
3.2 |
27,209
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.15 per share. |
02 Jan 2025 |
10,227 |
152,295
(0%)
|
0%
|
3.2 |
32,232
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 3.15 per share. |
02 Jan 2025 |
9,437 |
108,951
(0%)
|
0%
|
3.2 |
29,743
|
Common Stock |
|
Michael P Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 3.49 per share. |
12 Aug 2024 |
23,358 |
47,000
(0%)
|
0%
|
3.5 |
81,466
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.70 per share. |
17 Jul 2024 |
21,920 |
7,063,515
(17%)
|
0%
|
3.7 |
81,128
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.70 per share. |
17 Jul 2024 |
3,637 |
133,227
(0%)
|
0%
|
3.7 |
13,461
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.70 per share. |
17 Jul 2024 |
4,156 |
162,522
(0%)
|
0%
|
3.7 |
15,382
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
17 Jul 2024 |
2,598 |
118,388
(0%)
|
0%
|
3.7 |
9,615
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.27 per share. |
02 Jul 2024 |
18,885 |
7,085,435
(18%)
|
0%
|
3.3 |
61,726
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.27 per share. |
02 Jul 2024 |
4,349 |
136,864
(0%)
|
0%
|
3.3 |
14,215
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.27 per share. |
02 Jul 2024 |
5,295 |
166,678
(0%)
|
0%
|
3.3 |
17,307
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
02 Jul 2024 |
6,051 |
120,986
(0%)
|
0%
|
3.3 |
19,778
|
Common Stock |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
95,358
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
48,322
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
27,350
(0%)
|
0%
|
|
0
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
27,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
60,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
76,058
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alessandra Cesano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2024 |
27,000 |
54,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 3.34 per share. |
13 Jun 2024 |
22,000 |
21,322
(0%)
|
0%
|
3.3 |
73,467
|
Common Stock |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 3.33 per share. |
13 Jun 2024 |
27,000 |
350
(0%)
|
0%
|
3.3 |
89,902
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 3.33 per share. |
13 Jun 2024 |
27,000 |
0
(0%)
|
0%
|
3.3 |
89,818
|
Common Stock |
|
Allison Dorval
|
Director |
Sale of securities on an exchange or to another person at price $ 3.37 per share. |
13 Jun 2024 |
11,000 |
33,000
(0%)
|
0%
|
3.4 |
37,096
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Sale of securities on an exchange or to another person at price $ 3.39 per share. |
13 Jun 2024 |
9,900 |
49,058
(0%)
|
0%
|
3.4 |
33,528
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2024 |
9,047 |
9,047
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2024 |
6,577 |
7,104,320
(18%)
|
0%
|
|
0
|
Common Stock |
|
Hunt Douglas M.
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
37,894 |
141,213
(0%)
|
0%
|
|
0
|
Common Stock |
|
Wong F. Alvin
|
Chief Scientific Officer |
|
12 Feb 2024 |
43,307 |
141,241
(0%)
|
0%
|
|
0
|
Common Stock |
|
F. Nougues Maximo
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
59,946 |
59,946
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Auerbach Alan H.
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
160,796 |
7,097,743
(18%)
|
0%
|
|
0
|
Common Stock |
|
H. Auerbach Alan
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
222,573 |
222,573
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Ludwig Jeffrey Jerome
|
Chief Commercial Officer |
|
12 Feb 2024 |
27,067 |
127,037
(0%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
52,452 |
52,452
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jerome Ludwig Jeffrey
|
Chief Commercial Officer |
|
12 Feb 2024 |
37,466 |
37,466
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
F. Maximo Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
43,307 |
171,973
(0%)
|
0%
|
|
0
|
Common Stock |
|
F. Wong Alvin
|
Chief Scientific Officer |
|
12 Feb 2024 |
59,946 |
59,946
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan Auerbach H.
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 4.49 per share. |
03 Jan 2024 |
41,396 |
6,936,947
(17%)
|
0%
|
4.5 |
185,698
|
Common Stock |
|
Nougues Maximo F.
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 4.49 per share. |
03 Jan 2024 |
15,682 |
128,666
(0%)
|
0%
|
4.5 |
70,348
|
Common Stock |
|
Jeffrey Ludwig Jerome
|
Chief Commercial Officer |
|
03 Jan 2024 |
12,956 |
99,970
(0%)
|
0%
|
4.5 |
58,119
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
03 Jan 2024 |
7,733 |
98,214
(0%)
|
0%
|
4.5 |
34,689
|
Common Stock |
|
Douglas Hunt M.
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 4.49 per share. |
03 Jan 2024 |
8,358 |
103,319
(0%)
|
0%
|
4.5 |
37,493
|
Common Stock |
|
F. Wong Alvin
|
Chief Scientific Officer |
|
04 Dec 2023 |
280 |
97,934
(0%)
|
0%
|
3.8 |
1,053
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.31 per share. |
03 Jul 2023 |
60,698 |
6,978,343
(17%)
|
0%
|
3.3 |
200,983
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.31 per share. |
03 Jul 2023 |
7,809 |
111,677
(0%)
|
0%
|
3.3 |
25,857
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.31 per share. |
03 Jul 2023 |
14,680 |
144,348
(0%)
|
0%
|
3.3 |
48,608
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
03 Jul 2023 |
12,103 |
112,926
(0%)
|
0%
|
3.3 |
40,075
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
03 Jul 2023 |
6,938 |
105,947
(0%)
|
0%
|
3.3 |
22,973
|
Common Stock |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
68,358
(0%)
|
0%
|
|
0
|
Common Stock |
|
Michael P Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
13 Jun 2023 |
13,500 |
41,358
(0%)
|
0%
|
3.5 |
46,630
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
13 Jun 2023 |
22,000 |
16,322
(0%)
|
0%
|
3.5 |
75,970
|
Common Stock |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
43,322
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
27,350
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
13 Jun 2023 |
27,000 |
350
(0%)
|
0%
|
3.5 |
93,269
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
13 Jun 2023 |
27,000 |
0
(0%)
|
0%
|
3.5 |
93,280
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
27,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
44,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
13 Jun 2023 |
10,000 |
17,000
(0%)
|
0%
|
3.5 |
34,500
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Sale of securities on an exchange or to another person at price $ 3.46 per share. |
13 Jun 2023 |
9,900 |
31,958
(0%)
|
0%
|
3.5 |
34,252
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
58,958
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alessandra Cesano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
27,000 |
27,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
02 Jun 2023 |
269 |
112,885
(0%)
|
0%
|
3.4 |
928
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
258,924 |
258,924
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
186,403 |
7,039,041
(17%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
48,136 |
119,486
(0%)
|
0%
|
|
0
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
66,864 |
66,864
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
81,399 |
81,399
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2023 |
58,601 |
159,028
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
10 Feb 2023 |
66,972 |
125,029
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
10 Feb 2023 |
93,028 |
93,028
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
10 Feb 2023 |
81,399 |
81,399
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
10 Feb 2023 |
58,601 |
113,154
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 4.18 per share. |
03 Jan 2023 |
27,241 |
6,852,638
(17%)
|
0%
|
4.2 |
113,810
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 4.18 per share. |
03 Jan 2023 |
4,225 |
71,350
(0%)
|
0%
|
4.2 |
17,652
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 4.18 per share. |
03 Jan 2023 |
10,499 |
100,427
(0%)
|
0%
|
4.2 |
43,864
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
03 Jan 2023 |
6,568 |
58,057
(0%)
|
0%
|
4.2 |
27,440
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
03 Jan 2023 |
3,460 |
54,553
(0%)
|
0%
|
4.2 |
14,456
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 4.40 per share. |
12 Dec 2022 |
568,181 |
6,879,879
(17%)
|
1%
|
4.4 |
2,499,996
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 4.50 per share. |
02 Dec 2022 |
1,251 |
6,311,698
(16%)
|
0%
|
4.5 |
5,627
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 4.50 per share. |
02 Dec 2022 |
429 |
75,575
(0%)
|
0%
|
4.5 |
1,930
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 4.50 per share. |
02 Dec 2022 |
159 |
110,926
(0%)
|
0%
|
4.5 |
715
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
02 Dec 2022 |
514 |
58,013
(0%)
|
0%
|
4.5 |
2,312
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.25 per share. |
02 Nov 2022 |
1,242 |
6,312,949
(16%)
|
0%
|
2.3 |
2,795
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.25 per share. |
02 Nov 2022 |
429 |
76,004
(0%)
|
0%
|
2.2 |
965
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.25 per share. |
02 Nov 2022 |
163 |
111,085
(0%)
|
0%
|
2.3 |
367
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.34 per share. |
03 Oct 2022 |
1,260 |
6,314,191
(16%)
|
0%
|
2.3 |
2,943
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.34 per share. |
03 Oct 2022 |
435 |
76,433
(0%)
|
0%
|
2.3 |
1,016
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.33 per share. |
03 Oct 2022 |
165 |
111,248
(0%)
|
0%
|
2.3 |
385
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.59 per share. |
02 Sep 2022 |
1,254 |
6,315,451
(16%)
|
0%
|
2.6 |
3,247
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.59 per share. |
02 Sep 2022 |
433 |
76,868
(0%)
|
0%
|
2.6 |
1,121
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.59 per share. |
02 Sep 2022 |
164 |
111,413
(0%)
|
0%
|
2.6 |
425
|
Common Stock |
|
Michael P Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 3.55 per share. |
09 Aug 2022 |
25,000 |
54,858
(0%)
|
0%
|
3.6 |
88,793
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.89 per share. |
02 Aug 2022 |
1,247 |
6,316,705
(16%)
|
0%
|
2.9 |
3,604
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.89 per share. |
02 Aug 2022 |
429 |
77,301
(0%)
|
0%
|
2.9 |
1,240
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.89 per share. |
02 Aug 2022 |
161 |
111,577
(0%)
|
0%
|
2.9 |
465
|
Common Stock |
|
Alessandra Cesano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Jul 2022 |
100,000 |
100,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.63 per share. |
05 Jul 2022 |
26,140 |
6,317,952
(16%)
|
0%
|
2.6 |
68,787
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.63 per share. |
05 Jul 2022 |
3,753 |
77,730
(0%)
|
0%
|
2.6 |
9,876
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.63 per share. |
05 Jul 2022 |
9,328 |
111,738
(0%)
|
0%
|
2.6 |
24,547
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
05 Jul 2022 |
5,835 |
64,625
(0%)
|
0%
|
2.6 |
15,355
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
05 Jul 2022 |
2,920 |
58,527
(0%)
|
0%
|
2.6 |
7,684
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 2.64 per share. |
16 Jun 2022 |
22,858 |
38,322
(0%)
|
0%
|
2.6 |
60,370
|
Common Stock |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 2.58 per share. |
16 Jun 2022 |
27,858 |
27,350
(0%)
|
0%
|
2.6 |
71,971
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 2.63 per share. |
16 Jun 2022 |
27,858 |
27,000
(0%)
|
0%
|
2.6 |
73,303
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Sale of securities on an exchange or to another person at price $ 2.69 per share. |
16 Jun 2022 |
13,000 |
41,858
(0%)
|
0%
|
2.7 |
34,918
|
Common Stock |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
79,858
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
61,180
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
55,208
(0%)
|
0%
|
|
0
|
Common Stock |
|
Adrian Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
54,858
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
27,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2022 |
27,000 |
54,858
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 1.94 per share. |
02 Jun 2022 |
1,200 |
6,344,092
(16%)
|
0%
|
1.9 |
2,333
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 1.94 per share. |
02 Jun 2022 |
417 |
81,483
(0%)
|
0%
|
1.9 |
811
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 1.92 per share. |
02 Jun 2022 |
162 |
121,066
(0%)
|
0%
|
1.9 |
311
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
02 Jun 2022 |
587 |
61,447
(0%)
|
0%
|
1.9 |
1,129
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.32 per share. |
03 May 2022 |
1,263 |
6,345,292
(16%)
|
0%
|
2.3 |
2,930
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.31 per share. |
03 May 2022 |
438 |
81,900
(0%)
|
0%
|
2.3 |
1,012
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.34 per share. |
03 May 2022 |
165 |
121,228
(0%)
|
0%
|
2.3 |
386
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.34 per share. |
03 May 2022 |
165 |
121,228
(0%)
|
0%
|
2.3 |
386
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.34 per share. |
03 May 2022 |
165 |
121,228
(0%)
|
0%
|
2.3 |
386
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.08 per share. |
04 Apr 2022 |
1,198 |
6,346,555
(16%)
|
0%
|
3.1 |
3,687
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.08 per share. |
04 Apr 2022 |
413 |
82,338
(0%)
|
0%
|
3.1 |
1,271
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.08 per share. |
04 Apr 2022 |
206 |
121,393
(0%)
|
0%
|
3.1 |
634
|
Common Stock |
|
Michael P Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 2.80 per share. |
16 Mar 2022 |
25,653 |
52,858
(0%)
|
0%
|
2.8 |
71,792
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 2.79 per share. |
03 Mar 2022 |
1,792,114 |
6,347,753
(16%)
|
4%
|
2.8 |
4,999,998
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
168,824 |
4,555,639
(11%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
241,176 |
241,176
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
32,353 |
32,353
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
22,647 |
82,751
(0%)
|
0%
|
|
0
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
88,824 |
88,824
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2022 |
62,176 |
121,599
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
03 Mar 2022 |
55,882 |
55,882
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
03 Mar 2022 |
39,118 |
70,460
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
03 Mar 2022 |
64,118 |
64,118
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
03 Mar 2022 |
44,882 |
62,034
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.26 per share. |
02 Mar 2022 |
1,294 |
4,386,815
(11%)
|
0%
|
2.3 |
2,919
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.26 per share. |
02 Mar 2022 |
446 |
60,104
(0%)
|
0%
|
2.3 |
1,009
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.26 per share. |
02 Mar 2022 |
169 |
59,423
(0%)
|
0%
|
2.3 |
382
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.46 per share. |
02 Feb 2022 |
1,316 |
4,388,109
(11%)
|
0%
|
2.5 |
3,239
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.47 per share. |
02 Feb 2022 |
533 |
60,550
(0%)
|
0%
|
2.5 |
1,317
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.48 per share. |
02 Feb 2022 |
199 |
59,592
(0%)
|
0%
|
2.5 |
494
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.19 per share. |
03 Jan 2022 |
22,875 |
4,389,425
(11%)
|
0%
|
3.2 |
72,923
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.21 per share. |
03 Jan 2022 |
3,707 |
61,083
(0%)
|
0%
|
3.2 |
11,890
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.19 per share. |
03 Jan 2022 |
7,484 |
59,791
(0%)
|
0%
|
3.2 |
23,871
|
Common Stock |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
03 Jan 2022 |
4,727 |
31,342
(0%)
|
0%
|
3.2 |
15,121
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.90 per share. |
02 Dec 2021 |
1,837 |
4,412,300
(11%)
|
0%
|
2.9 |
5,327
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.90 per share. |
02 Dec 2021 |
441 |
64,790
(0%)
|
0%
|
2.9 |
1,279
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.95 per share. |
02 Dec 2021 |
162 |
67,275
(0%)
|
0%
|
3.0 |
478
|
Common Stock |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
02 Dec 2021 |
1,131 |
17,152
(0%)
|
0%
|
2.9 |
3,294
|
Common Stock |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.63 per share. |
02 Nov 2021 |
1,795 |
4,414,137
(11%)
|
0%
|
5.6 |
10,112
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 5.64 per share. |
02 Nov 2021 |
427 |
65,231
(0%)
|
0%
|
5.6 |
2,409
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.67 per share. |
02 Nov 2021 |
156 |
67,437
(0%)
|
0%
|
5.7 |
885
|
Common Stock |
|
Alan H. Auerbach
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 6.15 per share. |
04 Oct 2021 |
1,858 |
4,415,932
(11%)
|
0%
|
6.2 |
11,433
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 6.15 per share. |
04 Oct 2021 |
443 |
65,658
(0%)
|
0%
|
6.2 |
2,726
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 6.20 per share. |
04 Oct 2021 |
161 |
67,593
(0%)
|
0%
|
6.2 |
998
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 7.52 per share. |
02 Sep 2021 |
422 |
66,101
(0%)
|
0%
|
7.5 |
3,174
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 7.53 per share. |
02 Aug 2021 |
1,764 |
4,419,554
(11%)
|
0%
|
7.5 |
13,286
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 7.53 per share. |
02 Aug 2021 |
420 |
66,523
(0%)
|
0%
|
7.5 |
3,161
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 7.54 per share. |
02 Aug 2021 |
154 |
67,909
(0%)
|
0%
|
7.5 |
1,161
|
COMMON STOCK |
|
Allison Dorval
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2021 |
108,721 |
108,721
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 8.84 per share. |
02 Jul 2021 |
5,332 |
4,421,318
(11%)
|
0%
|
8.8 |
47,121
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 9.15 per share. |
02 Jul 2021 |
1,016 |
66,943
(0%)
|
0%
|
9.2 |
9,298
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 9.26 per share. |
02 Jul 2021 |
155 |
68,063
(0%)
|
0%
|
9.3 |
1,435
|
COMMON STOCK |
|
Alvin F. Wong
|
Chief Scientific Officer |
|
17 Jun 2021 |
90,000 |
90,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
78,511
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
34,180
(0%)
|
0%
|
|
0
|
Common Stock |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
28,208
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Adrian Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
27,858
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
27,858
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Ann C. Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
27,858 |
40,732
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Adrian Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 11.17 per share. |
11 Jun 2021 |
40,993 |
0
(0%)
|
0%
|
11.2 |
457,757
|
COMMON STOCK |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 11.36 per share. |
10 Jun 2021 |
25,248 |
6,322
(0%)
|
0%
|
11.4 |
286,860
|
Common Stock |
|
Ann C. Miller
|
Director |
Sale of securities on an exchange or to another person at price $ 11.43 per share. |
10 Jun 2021 |
12,874 |
12,874
(0%)
|
0%
|
11.4 |
147,156
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.74 per share. |
02 Jun 2021 |
1,757 |
4,426,650
(11%)
|
0%
|
10.7 |
18,877
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 10.77 per share. |
02 Jun 2021 |
416 |
67,959
(0%)
|
0%
|
10.8 |
4,481
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 10.74 per share. |
02 Jun 2021 |
152 |
68,218
(0%)
|
0%
|
10.7 |
1,633
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.01 per share. |
03 May 2021 |
1,758 |
4,428,407
(11%)
|
0%
|
9.0 |
15,847
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 9.91 per share. |
03 May 2021 |
417 |
68,375
(0%)
|
0%
|
9.9 |
4,133
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 9.91 per share. |
03 May 2021 |
152 |
68,370
(0%)
|
0%
|
9.9 |
1,506
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.80 per share. |
05 Apr 2021 |
1,584 |
4,430,165
(11%)
|
0%
|
9.8 |
15,528
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 9.80 per share. |
05 Apr 2021 |
426 |
121,662
(0%)
|
0%
|
9.8 |
4,176
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 9.80 per share. |
05 Apr 2021 |
426 |
68,792
(0%)
|
0%
|
9.8 |
4,176
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 9.80 per share. |
05 Apr 2021 |
155 |
68,522
(0%)
|
0%
|
9.8 |
1,519
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.14 per share. |
02 Mar 2021 |
1,238 |
4,431,749
(11%)
|
0%
|
10.1 |
12,556
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.15 per share. |
02 Mar 2021 |
422 |
122,088
(0%)
|
0%
|
10.1 |
4,283
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 10.16 per share. |
02 Mar 2021 |
422 |
69,218
(0%)
|
0%
|
10.2 |
4,288
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 10.14 per share. |
02 Mar 2021 |
154 |
68,677
(0%)
|
0%
|
10.1 |
1,561
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
149,951 |
4,432,987
(11%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
210,944 |
210,944
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
74,341 |
74,341
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
52,846 |
122,510
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
19,757 |
69,640
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
27,793 |
27,793
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
55,595 |
68,831
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Feb 2021 |
78,209 |
78,209
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
17 Feb 2021 |
36,069 |
36,069
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 12.22 per share. |
02 Feb 2021 |
1,222 |
4,283,036
(10%)
|
0%
|
12.2 |
14,931
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 12.23 per share. |
02 Feb 2021 |
415 |
69,664
(0%)
|
0%
|
12.2 |
5,076
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 12.27 per share. |
02 Feb 2021 |
412 |
49,883
(0%)
|
0%
|
12.3 |
5,054
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 12.26 per share. |
02 Feb 2021 |
179 |
13,236
(0%)
|
0%
|
12.3 |
2,195
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.22 per share. |
04 Jan 2021 |
18,235 |
4,284,258
(10%)
|
0%
|
10.2 |
186,380
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.23 per share. |
04 Jan 2021 |
6,548 |
70,079
(0%)
|
0%
|
10.2 |
67,016
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 10.23 per share. |
04 Jan 2021 |
6,463 |
50,295
(0%)
|
0%
|
10.2 |
66,145
|
Common Stock |
|
Maximo F. Nougues
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 10.22 per share. |
04 Jan 2021 |
2,145 |
13,415
(0%)
|
0%
|
10.2 |
21,930
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 11.66 per share. |
02 Dec 2020 |
355 |
4,302,493
(10%)
|
0%
|
11.7 |
4,138
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 11.65 per share. |
02 Dec 2020 |
92 |
76,627
(0%)
|
0%
|
11.7 |
1,072
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 7.81 per share. |
02 Nov 2020 |
371 |
4,302,848
(10%)
|
0%
|
7.8 |
2,899
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 7.81 per share. |
02 Nov 2020 |
97 |
76,719
(0%)
|
0%
|
7.8 |
758
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.13 per share. |
02 Oct 2020 |
350 |
4,303,219
(10%)
|
0%
|
10.1 |
3,545
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.14 per share. |
02 Oct 2020 |
91 |
76,816
(0%)
|
0%
|
10.1 |
923
|
COMMON STOCK |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 10.00 per share. |
16 Sep 2020 |
9,703 |
31,570
(0%)
|
0%
|
10 |
97,030
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.78 per share. |
02 Sep 2020 |
347 |
4,303,569
(10%)
|
0%
|
9.8 |
3,393
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 9.77 per share. |
02 Sep 2020 |
90 |
76,907
(0%)
|
0%
|
9.8 |
879
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.79 per share. |
03 Aug 2020 |
330 |
4,303,916
(10%)
|
0%
|
10.8 |
3,561
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.80 per share. |
03 Aug 2020 |
86 |
76,997
(0%)
|
0%
|
10.8 |
929
|
COMMON STOCK |
|
Brian M. Stuglik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jul 2020 |
93,953 |
93,953
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.66 per share. |
02 Jul 2020 |
2,607 |
4,304,246
(10%)
|
0%
|
10.7 |
27,803
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.67 per share. |
02 Jul 2020 |
660 |
77,083
(0%)
|
0%
|
10.7 |
7,040
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 10.69 per share. |
02 Jul 2020 |
572 |
56,758
(0%)
|
0%
|
10.7 |
6,112
|
Common Stock |
|
Jay M. Moyes
|
Director |
Sale of securities on an exchange or to another person at price $ 9.50 per share. |
16 Jun 2020 |
9,720 |
41,273
(0%)
|
0%
|
9.5 |
92,340
|
COMMON STOCK |
|
Troy E. Wilson
|
Director |
Sale of securities on an exchange or to another person at price $ 9.97 per share. |
11 Jun 2020 |
25,245 |
26,098
(0%)
|
0%
|
10.0 |
251,693
|
COMMON STOCK |
|
Adrian Senderowicz
|
Director |
Sale of securities on an exchange or to another person at price $ 9.89 per share. |
11 Jun 2020 |
10,000 |
40,993
(0%)
|
0%
|
9.9 |
98,878
|
COMMON STOCK |
|
Michael P Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
50,653
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Jay M. Moyes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
50,993
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Troy E. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
51,343
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Adrian Senderowicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
50,993
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Frank Zavrl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
50,993
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Hugh O'Dowd
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
25,748
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Ann C. Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2020 |
25,748 |
25,748
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.71 per share. |
02 Jun 2020 |
242 |
4,306,853
(10%)
|
0%
|
10.7 |
2,592
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.70 per share. |
02 Jun 2020 |
100 |
4,307,095
(10%)
|
0%
|
10.7 |
1,070
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.66 per share. |
02 Jun 2020 |
89 |
77,743
(0%)
|
0%
|
10.7 |
949
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.70 per share. |
04 May 2020 |
339 |
4,307,195
(10%)
|
0%
|
9.7 |
3,289
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 9.62 per share. |
04 May 2020 |
89 |
77,832
(0%)
|
0%
|
9.6 |
856
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 7.39 per share. |
02 Apr 2020 |
347 |
4,307,534
(10%)
|
0%
|
7.4 |
2,563
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 7.37 per share. |
02 Apr 2020 |
91 |
77,921
(0%)
|
0%
|
7.4 |
671
|
COMMON STOCK |
|
Jeffrey Jerome Ludwig
|
Chief Commercial Officer |
|
20 Mar 2020 |
320,000 |
320,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.02 per share. |
02 Mar 2020 |
372 |
4,307,881
(10%)
|
0%
|
10.0 |
3,726
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.02 per share. |
02 Mar 2020 |
96 |
78,012
(0%)
|
0%
|
10.0 |
962
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Feb 2020 |
4,500 |
57,330
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
127,553 |
4,308,253
(10%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
161,649 |
161,649
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
54,842 |
54,842
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
43,274 |
78,108
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
54,842 |
54,842
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
43,274 |
54,558
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
15,560 |
15,560
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2020 |
15,567 |
15,567
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 8.02 per share. |
03 Feb 2020 |
331 |
4,180,700
(10%)
|
0%
|
8.0 |
2,653
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 8.02 per share. |
03 Feb 2020 |
105 |
34,834
(0%)
|
0%
|
8.0 |
842
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 8.33 per share. |
02 Jan 2020 |
43 |
4,187,004
(10%)
|
0%
|
8.3 |
358
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 8.39 per share. |
02 Jan 2020 |
5,973 |
4,181,031
(10%)
|
0%
|
8.4 |
50,113
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 8.40 per share. |
02 Jan 2020 |
1,514 |
34,939
(0%)
|
0%
|
8.4 |
12,718
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 8.50 per share. |
02 Jan 2020 |
2 |
36,453
(0%)
|
0%
|
8.5 |
17
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 8.43 per share. |
02 Jan 2020 |
1,405 |
11,284
(0%)
|
0%
|
8.4 |
11,847
|
Common Stock |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.33 per share. |
02 Dec 2019 |
455 |
4,187,047
(10%)
|
0%
|
10.3 |
4,700
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.34 per share. |
02 Dec 2019 |
83 |
36,455
(0%)
|
0%
|
10.3 |
858
|
COMMON STOCK |
|
Ann C. Miller
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Nov 2019 |
125,306 |
125,306
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 7.40 per share. |
04 Nov 2019 |
100 |
4,187,502
(10%)
|
0%
|
7.4 |
740
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 7.40 per share. |
04 Nov 2019 |
378 |
4,187,602
(10%)
|
0%
|
7.4 |
2,797
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 7.38 per share. |
04 Nov 2019 |
88 |
36,538
(0%)
|
0%
|
7.4 |
649
|
COMMON STOCK |
|
Hugh O'Dowd
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Oct 2019 |
85,201 |
85,201
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.97 per share. |
02 Oct 2019 |
504 |
4,187,980
(10%)
|
0%
|
10.0 |
5,027
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.05 per share. |
02 Oct 2019 |
91 |
36,626
(0%)
|
0%
|
10.1 |
915
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 11.42 per share. |
10 Sep 2019 |
1,711 |
12,689
(0%)
|
0%
|
11.4 |
19,540
|
Common Stock |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Sep 2019 |
4,500 |
14,400
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.14 per share. |
04 Sep 2019 |
524 |
4,188,484
(10%)
|
0%
|
10.1 |
5,313
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.11 per share. |
04 Sep 2019 |
95 |
36,717
(0%)
|
0%
|
10.1 |
960
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.00 per share. |
02 Aug 2019 |
1 |
4,189,008
(10%)
|
0%
|
9 |
9
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.03 per share. |
02 Aug 2019 |
516 |
4,189,009
(10%)
|
0%
|
9.0 |
4,659
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 9.00 per share. |
02 Aug 2019 |
94 |
36,812
(0%)
|
0%
|
9 |
846
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 9.98 per share. |
22 Jul 2019 |
12,715 |
4,189,525
(10%)
|
0%
|
10.0 |
126,846
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 10.04 per share. |
22 Jul 2019 |
1,852 |
19,557
(0%)
|
0%
|
10.0 |
18,600
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 10.10 per share. |
22 Jul 2019 |
1,841 |
36,906
(0%)
|
0%
|
10.1 |
18,589
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 12.78 per share. |
02 Jul 2019 |
495 |
4,202,240
(10%)
|
0%
|
12.8 |
6,326
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 12.78 per share. |
02 Jul 2019 |
89 |
38,747
(0%)
|
0%
|
12.8 |
1,137
|
COMMON STOCK |
|
Michael P Miller
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2019 |
19,423 |
24,905
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2019 |
19,423 |
25,245
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2019 |
19,423 |
25,595
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2019 |
19,423 |
25,245
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2019 |
19,423 |
25,245
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 15.18 per share. |
03 Jun 2019 |
483 |
4,202,735
(10%)
|
0%
|
15.2 |
7,332
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 15.07 per share. |
03 Jun 2019 |
88 |
38,836
(0%)
|
0%
|
15.1 |
1,326
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 32.38 per share. |
02 May 2019 |
477 |
4,203,218
(10%)
|
0%
|
32.4 |
15,445
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 32.38 per share. |
02 May 2019 |
85 |
38,924
(0%)
|
0%
|
32.4 |
2,752
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 35.79 per share. |
02 Apr 2019 |
491 |
4,203,695
(10%)
|
0%
|
35.8 |
17,573
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 35.78 per share. |
02 Apr 2019 |
88 |
39,009
(0%)
|
0%
|
35.8 |
3,149
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 38.62 per share. |
04 Mar 2019 |
496 |
4,204,186
(10%)
|
0%
|
38.6 |
19,156
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 38.66 per share. |
04 Mar 2019 |
88 |
39,097
(0%)
|
0%
|
38.7 |
3,402
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
62,634 |
62,634
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
39,215 |
4,204,682
(10%)
|
0%
|
|
0
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
36,300 |
36,300
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
9,900 |
39,185
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
15,400 |
15,400
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
15,400 |
15,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2019 |
9,900 |
9,900
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 27.80 per share. |
04 Feb 2019 |
345 |
4,165,467
(10%)
|
0%
|
27.8 |
9,591
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 27.64 per share. |
04 Feb 2019 |
87 |
31,957
(0%)
|
0%
|
27.6 |
2,405
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 27.78 per share. |
04 Feb 2019 |
89 |
29,285
(0%)
|
0%
|
27.8 |
2,472
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 24.74 per share. |
22 Jan 2019 |
8,825 |
4,165,812
(10%)
|
0%
|
24.7 |
218,334
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 24.80 per share. |
22 Jan 2019 |
713 |
32,044
(0%)
|
0%
|
24.8 |
17,682
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 24.91 per share. |
22 Jan 2019 |
2,114 |
21,409
(0%)
|
0%
|
24.9 |
52,664
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 24.72 per share. |
22 Jan 2019 |
1,959 |
29,374
(0%)
|
0%
|
24.7 |
48,426
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 20.67 per share. |
03 Jan 2019 |
4,424 |
4,174,637
(10%)
|
0%
|
20.7 |
91,444
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 20.67 per share. |
03 Jan 2019 |
1,210 |
32,757
(0%)
|
0%
|
20.7 |
25,011
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 20.67 per share. |
03 Jan 2019 |
1,210 |
31,333
(0%)
|
0%
|
20.7 |
25,011
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 22.77 per share. |
03 Dec 2018 |
1,239 |
33,967
(0%)
|
0%
|
22.8 |
28,212
|
COMMON STOCK |
|
Maximo F. Nougues
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2018 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 52.00 per share. |
20 Jul 2018 |
12,520 |
4,179,061
(11%)
|
0%
|
52.0 |
651,020
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 51.95 per share. |
20 Jul 2018 |
610 |
35,206
(0%)
|
0%
|
52.0 |
31,690
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 51.85 per share. |
20 Jul 2018 |
1,839 |
23,523
(0%)
|
0%
|
51.9 |
95,360
|
COMMON STOCK |
|
Richard P. Bryce
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 51.95 per share. |
20 Jul 2018 |
1,836 |
32,543
(0%)
|
0%
|
52.0 |
95,381
|
COMMON STOCK |
|
Michael P Miller
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2018 |
5,482 |
5,482
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2018 |
5,822 |
5,822
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2018 |
5,822 |
6,172
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2018 |
5,822 |
5,822
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2018 |
5,822 |
5,822
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 53.00 per share. |
01 Jun 2018 |
1,211 |
35,816
(0%)
|
0%
|
53 |
64,183
|
COMMON STOCK |
|
Michael P Miller
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Feb 2018 |
17,626 |
17,626
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
56,940 |
56,940
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
35,650 |
4,191,581
(11%)
|
0%
|
|
0
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
9,000 |
37,027
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
14,000 |
14,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
33,000 |
33,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2018 |
9,000 |
34,379
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 92.75 per share. |
22 Jan 2018 |
10,692 |
4,155,931
(11%)
|
0%
|
92.8 |
991,683
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 92.85 per share. |
22 Jan 2018 |
669 |
28,027
(0%)
|
0%
|
92.9 |
62,117
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 92.85 per share. |
22 Jan 2018 |
1,858 |
25,362
(0%)
|
0%
|
92.8 |
172,515
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 92.75 per share. |
22 Jan 2018 |
1,860 |
25,379
(0%)
|
0%
|
92.8 |
172,515
|
COMMON STOCK |
|
Douglas M. Hunt
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2018 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 105.46 per share. |
01 Dec 2017 |
1,322 |
28,696
(0%)
|
0%
|
105.5 |
139,424
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Sep 2017 |
15,000 |
67,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. |
29 Sep 2017 |
15,000 |
42,239
(0%)
|
0%
|
11.3 |
169,500
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 120.00 per share. |
29 Sep 2017 |
15,000 |
27,239
(0%)
|
0%
|
120 |
1,800,000
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. |
06 Sep 2017 |
1,000 |
28,239
(0%)
|
0%
|
11.3 |
11,300
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Sep 2017 |
1,000 |
96,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Sep 2017 |
14,000 |
82,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 100.10 per share. |
06 Sep 2017 |
14,000 |
27,239
(0%)
|
0%
|
100.1 |
1,401,400
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. |
06 Sep 2017 |
14,000 |
41,239
(0%)
|
0%
|
11.3 |
158,200
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
06 Sep 2017 |
1,000 |
27,239
(0%)
|
0%
|
100 |
100,000
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 94.34 per share. |
20 Jul 2017 |
9,175 |
4,170,623
(11%)
|
0%
|
94.3 |
865,605
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 95.60 per share. |
20 Jul 2017 |
4,000 |
4,166,623
(11%)
|
0%
|
95.6 |
382,400
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 95.15 per share. |
20 Jul 2017 |
662 |
30,018
(0%)
|
0%
|
95.2 |
62,991
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 94.90 per share. |
20 Jul 2017 |
1,990 |
27,220
(0%)
|
0%
|
94.9 |
188,853
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 95.14 per share. |
20 Jul 2017 |
7 |
27,239
(0%)
|
0%
|
95.1 |
666
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 94.48 per share. |
20 Jul 2017 |
1,991 |
27,246
(0%)
|
0%
|
94.5 |
188,111
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jul 2017 |
5,000 |
97,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. |
03 Jul 2017 |
5,000 |
34,237
(0%)
|
0%
|
11.3 |
56,500
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 87.10 per share. |
03 Jul 2017 |
5,000 |
29,237
(0%)
|
0%
|
87.1 |
435,500
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2017 |
7,604 |
7,604
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2017 |
7,604 |
7,604
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2017 |
7,604 |
7,604
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2017 |
7,604 |
7,604
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 May 2017 |
21,000 |
30,680
(0%)
|
0%
|
|
0
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2017 |
70,000 |
70,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2017 |
31,500 |
31,500
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2017 |
31,500 |
31,500
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2017 |
31,500 |
31,500
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Robert Charnas
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2017 |
15,750 |
15,750
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 33.24 per share. |
20 Jan 2017 |
10,202 |
4,179,798
(11%)
|
0%
|
33.2 |
339,064
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Sale of securities on an exchange or to another person at price $ 33.24 per share. |
20 Jan 2017 |
820 |
9,680
(0%)
|
0%
|
33.2 |
27,253
|
COMMON STOCK |
|
Steven Lo
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 33.23 per share. |
20 Jan 2017 |
2,290 |
29,210
(0%)
|
0%
|
33.2 |
76,108
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 33.24 per share. |
20 Jan 2017 |
2,293 |
29,237
(0%)
|
0%
|
33.2 |
76,208
|
COMMON STOCK |
|
Robert Charnas
|
Other |
Sale of securities on an exchange or to another person at price $ 33.23 per share. |
20 Jan 2017 |
2,239 |
29,461
(0%)
|
0%
|
33.2 |
74,413
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Nov 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Nov 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Nov 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Nov 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Oct 2016 |
150,000 |
4,190,000
|
-
|
|
-
|
COMMON STOCK |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Oct 2016 |
10,500 |
10,500
|
-
|
|
-
|
Common Stock |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Oct 2016 |
31,500 |
31,500
|
-
|
|
-
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Oct 2016 |
31,500 |
31,530
|
-
|
|
-
|
COMMON STOCK |
|
Robert Charnas
|
Other |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Oct 2016 |
31,500 |
31,700
|
-
|
|
-
|
COMMON STOCK |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2016 |
66,667 |
66,667
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2016 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2016 |
30,000 |
30,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2016 |
41,250 |
41,250
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard B. Phillips
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Apr 2016 |
25,000 |
25,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Apr 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Apr 2016 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Dec 2015 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Dec 2015 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Dec 2015 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Dec 2015 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Oct 2015 |
31,500 |
31,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Oct 2015 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Steven Lo
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Sep 2015 |
150,000 |
150,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Sep 2015 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Sep 2015 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Sep 2015 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Frank Zavrl
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Sep 2015 |
30,000 |
30,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Aug 2015 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adrian Senderowicz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Aug 2015 |
30,000 |
30,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Aug 2015 |
31,500 |
31,500
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Jul 2015 |
3,000 |
102,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
06 Jul 2015 |
3,000 |
30
|
-
|
|
-
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Jul 2015 |
3,000 |
3,030
|
-
|
|
-
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2014 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2014 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Thomas R. Malley
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2014 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2014 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Nov 2014 |
31,500 |
31,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jul 2014 |
31,500 |
31,500
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
09 Apr 2014 |
2 |
2
|
-
|
|
-
|
COMMON STOCK |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
09 Apr 2014 |
28 |
30
|
-
|
|
-
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2013 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Thomas R. Malley
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2013 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2013 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Nov 2013 |
31,500 |
31,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Richard B. Phillips
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Nov 2013 |
31,500 |
31,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Oct 2013 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Troy E. Wilson
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Oct 2013 |
40,000 |
40,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jul 2013 |
36,750 |
36,750
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Alan H. Auerbach
|
Director, PRESIDENT AND CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Dec 2012 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles R. Eyler
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Dec 2012 |
22,500 |
22,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Richard B. Phillips
|
SEE REMARKS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Dec 2012 |
31,500 |
31,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alan H. Auerbach
|
Director, PRESIDENT, CEO & SECRETARY, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Oct 2012 |
2,116,250 |
2,116,250
|
-
|
|
-
|
Warrant to Purchase Common Stock |
|
Thomas R. Malley
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
24 Oct 2012 |
10,000 |
156,551
|
-
|
|
-
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Oct 2012 |
20,000 |
20,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Oct 2012 |
20,000 |
20,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Thomas R. Malley
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Oct 2012 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Thomas R. Malley
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Oct 2012 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Richard P. Bryce
|
SR VP, CLINICAL RESEARCH & DEV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Jun 2012 |
105,000 |
105,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Thomas R. Malley
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
11 Jun 2012 |
10,032 |
146,551
|
-
|
|
-
|
COMMON STOCK |
|
Thomas R. Malley
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
07 Jun 2012 |
8,168 |
136,519
|
-
|
|
-
|
COMMON STOCK |
|
Thomas R. Malley
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
07 Jun 2012 |
1,800 |
128,351
|
-
|
|
-
|
COMMON STOCK |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Apr 2012 |
30,000 |
30,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |
|
Jay M. Moyes
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Apr 2012 |
10,000 |
10,000
|
-
|
|
-
|
STOCK OPTION (RIGHT TO BUY) |